View graph of relations
  1. 2019
  2. Published
  3. Published
  4. Published
  5. Published
    Eggebrecht, L., Prochaska, J. H., Troebs, S-O., Schwuchow-Thonke, S., Goebel, S., Diestelmeier, S., ... Wild, P. S. (2019). Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism. Clinical research in cardiology, 108(7), 787-796. https://doi.org/10.1007/s00392-018-1408-y
  6. Published
  7. Published
  8. Published
  9. Published
  10. Published
  11. Published
  12. Published
  13. Published
  14. Published
  15. Published
  16. Published
  17. Published
  18. Published
  19. Published
    Ratzon, R., Tamir, S., Friehmann, T., Livneh, N., Dudnik, E., Rozental, A., ... Leader, A. (2019). Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndrome. Journal of Thrombosis and Thrombolysis, 47(1), 121-128. https://doi.org/10.1007/s11239-018-1747-6
  20. Published
  21. 2018
  22. Published
  23. Published
    Prochaska, J. H., Goebel, S., Nagler, M., Knoepfler, T., Eggebrecht, L., Lamparter, H., ... Wild, P. S. (2018). Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure. Clinical research in cardiology, 107(12), 1170-1179. https://doi.org/10.1007/s00392-018-1293-4
  24. Published
  25. Published
  26. Published
  27. Published
    Goebel, S., Prochaska, J. H., Eggebrecht, L., Schmitz, R., Juenger, C., Lamparter, H., ... Wild, P. S. (2018). Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL Study. Thrombosis and Haemostasis, 118(11), 1930-1939. https://doi.org/10.1055/s-0038-1673380
  28. Published
  29. Published
  30. Published
  31. Published
  32. Published
  33. Published
  34. Published
  35. Published
  36. Published
  37. Published
  38. Published
  39. Published
  40. Published
  41. Published
    Panova-Noeva, M., Schulz, A., Arnold, N., Hermanns, M. I., Prochaska, J. H., Laubert-Reh, D., ... Wild, P. S. (2018). Coagulation and inflammation in long-term cancer survivors: results from the adult population. Journal of Thrombosis and Haemostasis, 16(4), 699-708. https://doi.org/10.1111/jth.13975
  42. Published
  43. Published
  44. Published
  45. Published
    Borst, O., Munzer, P., Alnaggar, N., Geue, S., Tegtmeyer, R., Rath, D., ... Geisler, T. (2018). Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction. Blood advances, 2(6), 715-730. https://doi.org/10.1182/bloodadvances.2017013573
  46. Published
  47. Published
  48. Published
  49. Published
  50. Published
    Brekelmans, M. P. A., Abdoellakhan, R. A., Scheres, L. J. J., Biedermann, J. S., Hutten, B. A., Meijer, K., ... Coppens, M. (2018). Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrate. Research and practice in thrombosis and haemostasis, 2(1), 77-84. https://doi.org/10.1002/rth2.12055
  51. Published
  52. 2017
  53. Published
Previous 1 2 3 4 5 Next